www.eventura.site
Open in
urlscan Pro
54.157.107.32
Public Scan
URL:
https://www.eventura.site/courses/navigating-the-fda-s-guidelines-on-off-label-promotions?utm_source=mailchimp&utm_medium=...
Submission: On April 17 via manual from US — Scanned from DE
Submission: On April 17 via manual from US — Scanned from DE
Form analysis 0 forms found in the DOM
Text Content
Eventura World * Eventura World * Courses * * Eventura World * * * Eventura World * Courses 1. Eventura World 2. Courses 3. NAVIGATING THE FDA'S GUIDELINES ON OFF-LABEL PROMOTIONS NAVIGATING THE FDA'S GUIDELINES ON OFF-LABEL PROMOTIONS -------------------------------------------------------------------------------- 🎤 Kelly Thomas | 📅 April 27, 2023 | 🕒 11 AM Eastern Time US -------------------------------------------------------------------------------- Description: The FDA has jurisdiction over the labeling and advertising of prescription drugs and medical devices. On the other hand, the responsibility for regulating advertising for non-prescription or over-the-counter drugs falls under another federal agency. In the pharmaceutical and medical device industry, companies and their representatives often distribute scientific or medical publications containing information on off-label uses (unapproved uses) of FDA approved or cleared drugs or medical devices to healthcare professionals or entities. However, it is important for firms to comply with the FDA's guidelines on how to communicate off-label uses to healthcare professionals. This webinar is designed to provide insight into the FDA's current policy on the dissemination of scientific or medical references that include information on off-label uses of approved or cleared medical products. Attendees will learn the recommended practices for manufacturers to stay compliant with the FDA's policy on off-label promotion. -------------------------------------------------------------------------------- AREAS COVERED IN THE SESSION: * Applicable Statute(s) and Regulations * Definitions * Regulatory Requirements * FDA’s Monitoring and Surveillance Program * FDA’s Current Policy on the Issues * Implementing Good Medical and Scientific Publication Practices on Off Label Uses * FDA’s Untitled Letter Analysis * Common Avoidable Mistakes * How to Prevent Common Mistakes * How to Avoid FDA’s Actions * Conclusion WHO SHOULD ATTEND: * Quality Assurance Departments * Regulatory Affairs Departments * Compliance Officers * Clinical Affairs Professionals * Research and Development Departments * Consultants * All upper and mid-management professionals * Contractors/Subcontractors -------------------------------------------------------------------------------- FDA Promotions Off-Label * * * * COMPUTER SYSTEM VALIDATION (CSV) AND DATA INTEGRITY FOR CLINICAL TRIALS REGULATED BY FDA TECHNICAL WRITING MASTERCLASS IN THE LIFE SCIENCES QUALITY CONTROL LABORATORY COMPLIANCE - cGMP AND GLP TRAINING Eventura World Copyright © 2023 All rights reserved Powered By SITE123 - Website maker * Eventura World * Courses